Can inflammation and other stressors lower T4-to-T3 conversion even when TSH and free T4 are normal?

The peripheral conversion of thyroxine (T4) to biologically active triiodothyronine (T3) is highly sensitive to systemic physiological stressors. Under certain clinical conditions, this enzymatic pathway is compromised even when standard thyroid markers appear normal.

Molecular mechanisms of impairment

• Cytokine and stress signaling: Pro-inflammatory cytokines (IL-6, TNF-α, and IL-1β) and elevated cortisol downregulate Type 1 (D1) and Type 2 (D2) deiodinases. Concurrently, they upregulate Type 3 (D3) deiodinase, shunting T4 into inactive reverse T3 (rT3).
• Oxidative stress: IL-6-mediated inflammation increases reactive oxygen species (ROS) and depletes intracellular glutathione. This resulting oxidative stress directly impairs the catalytic function of the remaining deiodinase enzymes.

Micronutrient and genetic modulators

• Nutritional cofactors: Deiodinases are selenium-dependent selenoproteins and zinc-dependent metalloenzymes. Deficiencies in selenium and zinc restrict deiodinase synthesis and structural activity, while selenium depletion further compromises glutathione-dependent antioxidant defenses, amplifying oxidative stress.
• Genetic variants: The DIO2 Thr92Ala (rs225014) polymorphism reduces baseline intracellular D2 efficiency, lowering the T3/T4 ratio at the tissue level.

Clinical presentation

• Subclinical divergence: These combined mechanisms lower peripheral T4-to-T3 conversion without triggering a compensatory rise in TSH. Consequently, patients present with reduced active T3 and elevated rT3, despite clinically normal TSH and free T4 levels, resembling non-thyroidal illness syndrome (NTIS).

Bottom line

• Inflammatory, endocrine, nutritional, and genetic factors can synergistically impair peripheral T4-to-T3 conversion, causing cellular hypothyroid states that escape detection on standard TSH and free T4 screening panels.